Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
My New York City practice has been a refractive-only practice for more than 25 years, offering the full range of FDA-approved vision correction surgery options, from lasers to IOLs.
The rate-limiting factors for presbyopia-correcting IOLs, in my opinion, have long been dysphotopsias and enhancements. When I first started implanting presbyopia-correcting IOLs, the side effect profile — primarily problems with night vision — was significant, and achieving good vision at all distances was challenging. Early on, I explanted about 4% to 5% of the multifocal IOLs I implanted and performed laser